Ozempic and other weight-loss drugs will power the anti-obesity market to 16-fold gains by 2030, Goldman Sachs says
Weight-loss drugs could fuel huge gains for the anti-obesity market, according to Goldman Sachs. Getty Images The anti-obesity market could…